Guangdong Lifestrong Pharmacy Co., Ltd. (301111.SZ)
CNY 14.53
(-0.27%)
CNY 14.53
(-0.27%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 292.39 Million | 283.33 Million | 349.78 Million | 340.95 Million | 316.58 Million | 290.49 Million |
| Cost of Revenue | 91.94 Million | 92.1 Million | 107.21 Million | 114.34 Million | 87.58 Million | 89.79 Million |
| Gross Profit | 200.45 Million | 191.22 Million | 242.57 Million | 226.61 Million | 229 Million | 200.7 Million |
| Operating Expenses | 159.26 Million | 163.89 Million | 176.66 Million | 153.8 Million | 145.18 Million | 122.09 Million |
| Selling, General and Administrative Expenses | 147.99 Million | 145.3 Million | 156.14 Million | 108.99 Million | 82.38 Million | 70.14 Million |
| Research and Development Expenses | 8.44 Million | 9.16 Million | 10.86 Million | 10.54 Million | 7.81 Million | 7.04 Million |
| Other Expenses | - | -8.35 Million | -3.53 Million | -3.06 Million | -12.45 Million | 345.9 Thousand |
| Cost and Expenses | 251.21 Million | 256 Million | 283.87 Million | 268.14 Million | 232.76 Million | 211.88 Million |
| Operating Income | 41.18 Million | 43.1 Million | 70.26 Million | 72.69 Million | 84.15 Million | 74.56 Million |
| Interest Expense | 398.52 Thousand | 27.8 Thousand | 56.35 Thousand | 146.69 Thousand | 42.66 Thousand | 4.15 Million |
| Income Tax Expense | 4.75 Million | 1.33 Million | 9.54 Million | 9.94 Million | 13.54 Million | 10.78 Million |
| Earnings before Tax | 37.29 Million | 34.75 Million | 66.72 Million | 72.46 Million | 80.17 Million | 74.38 Million |
| Net Income | 33.5 Million | 33.41 Million | 57.18 Million | 62.52 Million | 66.63 Million | 63.6 Million |
| Earnings Per Share Basic | 0.21 | 0.21 | 0.36 | 0.39 | 0.42 | 0.53 |
| Earnings Per Share Diluted | 0.21 | 0.21 | 0.36 | 0.39 | 0.42 | 0.53 |
| Weighted Average Shares Outstanding | 159.53 Million | 160 Million | 160 Million | 160 Million | 160 Million | 120 Million |
| Weighted Average Shares Outstanding (Diluted) | 159.53 Million | 160 Million | 160 Million | 160 Million | 160 Million | 120 Million |
| Gross Margin | 0.69 | 0.67 | 0.69 | 0.66 | 0.72 | 0.69 |
| EBIT Margin | 0.17 | 0.16 | 0.23 | 0.25 | 0.33 | 0.33 |
| Profit Margin | 0.11 | 0.12 | 0.16 | 0.18 | 0.21 | 0.22 |
| EBITDA | 50.95 Million | 46.99 Million | 81.63 Million | 84 Million | 103.52 Million | 83.17 Million |
| Earnings Before Tax Margin | 0.14 | 0.15 | 0.20 | 0.21 | 0.27 | 0.26 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 75.48 Million | 79.98 Million | 70.07 Million | 86.35 Million | 292.39 Million | 59.2 Million |
| Cost of Revenue | 30.52 Million | 38.09 Million | 24.7 Million | 25.15 Million | 91.94 Million | 17.01 Million |
| Gross Profit | 44.95 Million | 41.89 Million | 45.37 Million | 61.19 Million | 200.45 Million | 42.19 Million |
| Operating Expenses | 50.77 Million | 43.4 Million | 37.21 Million | 51.7 Million | 169.64 Million | 41.12 Million |
| Selling, General and Administrative Expenses | 48.01 Million | 42.65 Million | 36.34 Million | 34.87 Million | - | 47.63 Million |
| Research and Development Expenses | 2.18 Million | 1.68 Million | 2.26 Million | 2.22 Million | - | 2.06 Million |
| Other Expenses | -585.8 Thousand | 933.04 Thousand | 1.39 Million | -3.75 Million | -3.89 Million | 2794.66 |
| Cost and Expenses | 81.3 Million | 81.49 Million | 61.91 Million | 76.86 Million | 261.58 Million | 58.14 Million |
| Operating Income | -5.82 Million | -1.51 Million | 8.15 Million | 6.07 Million | 41.18 Million | 6.01 Million |
| Interest Expense | 78.14 Thousand | - | 139.6 Thousand | 163.55 Thousand | 368.7 Thousand | 138.97 Thousand |
| Income Tax Expense | -665.94 Thousand | -735.33 Thousand | 2.05 Million | 24.11 Thousand | 4.75 Million | 529.36 Thousand |
| Earnings before Tax | -2.08 Million | 3.28 Million | 13.52 Million | 2.31 Million | 37.29 Million | 6.02 Million |
| Net Income | -1 Million | 3.36 Million | 11.73 Million | 3 Million | 33.5 Million | 5.68 Million |
| Earnings Per Share Basic | -0.01 | 0.02 | 0.07 | 0.02 | - | 0.04 |
| Earnings Per Share Diluted | -0.01 | 0.02 | 0.07 | 0.02 | - | 0.04 |
| Weighted Average Shares Outstanding | 160 Million | 160 Million | 160 Million | 154.13 Million | 159.53 Million | 160 Million |
| Weighted Average Shares Outstanding (Diluted) | 160 Million | 160 Million | 160 Million | 154.13 Million | 159.53 Million | 160 Million |
| Gross Margin | 0.60 | 0.52 | 0.65 | 0.71 | 0.69 | 0.71 |
| EBIT Margin | -0.03 | 0.02 | 0.14 | 0.11 | - | 0.08 |
| Profit Margin | -0.01 | 0.04 | 0.17 | 0.03 | 0.11 | 0.10 |
| EBITDA | -2 Million | 1.64 Million | 9.73 Million | 9.14 Million | - | 4.68 Million |
| Earnings Before Tax Margin | -0.08 | -0.02 | 0.12 | 0.07 | 0.14 | 0.10 |
LKFN
HVO
8013
APEX
INVERCAP
3628